|
|
Vaccine Detail
|
Chimeric exosomal tumor vaccine |
| Vaccine Information |
- Vaccine Name: Chimeric exosomal tumor vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: Subunit vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Immunization Route: Other
- Description: Personalized chimeric exosome vaccines are prepared as tumor cells are isolated from the lesion site of patients with recurrent or metastatic bladder cancer, and dendritic cells or macrophages are isolated from peripheral blood. The vaccine activates an immune response and the microenvironment of bladder cancer lesions, and improves the anti-recurrence treatment effect of bladder cancer. (NCT05559177)
|
| Host Response |
|
|
| References |
NCT05559177: An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer [https://clinicaltrials.gov/study/NCT05559177]
|
|
